Ddiscover how Standigm’s use of Synthiaᵀᴹ can accelerate AI-driven drug discovery

Click the button below to register
and view a recording of the webinar

Register and view now

In this hour-long, interactive webinar Standigm showcase its innovative use of Synthia web-app, Synthia SAS API, and Synthia full retro API designed to revolutionise drug discovery through AI.

Discover how these tools are bridging critical gaps in medical research by accelerating the development of therapeutic solutions. Ideal for professionals in chemistry, biology, and AI, this session will serve as a comprehensive tutorial, enhancing your understanding of AI’s transformative role in pharmaceuticals.

By watching the recording of this webinar you will learn:

• How Standigm integrates Synthia’s tools to expedite the drug discovery process, enhancing efficiency and output

• The specific functionalities and advantages of the Synthia web-app, Synthia SAS API, and full retro API in real-world pharmaceutical applications

• Strategies for leveraging AI in drug discovery to identify and assess novel drug targets and design effective molecular modulators

Don’t miss this opportunity to hear from guest speakers at the forefront of AI-driven drug discovery advancements, and ask your questions throughout the session.

Portrait headshot of Ewa Gajewska

Ewa Gajewska

Ewa Gajewska is head of product management in Merck, where she leads the development of Synthia Retrosynthesis Software. She graduated in biotechnology and chemistry from the Gdansk University of Technology, Poland, and was a recipient of the Outstanding Achievements Award from Poland’s Minister of Science and Higher Education. In 2020 she received her PhD from the Institute of Organic Chemistry at the Polish Academy of Sciences. Her doctoral work was devoted to development of the Synthia Retrosynthesis Software for computer-assisted synthetic planning. Her passion for tackling complex scientific challenges within commercial settings and the unique addition of her interdisciplinary skills drives the realisation of Synthia Retrosynthesis Software’s innovative features.

 

Portrait headshot of You Young Song

You Young Song

You Young Song is a principal AI scientist at Standigm, specialising in generative and synthesis AI for drug discovery. Song holds a degree in computer science and technology, and mathematics from Postech, South Korea, and earned her PhD from the Graduate Institute of Ferrous & Energy Materials Technology at Postech, South Korea. Throughout her doctoral studies and before joining Standigm, she focused on computer-based simulations to develop novel-enhanced materials, which ultimately led her to dedicate herself to AI-based drug discovery.

Click the button below to register
and view a recording of the webinar

Register and view now

Merck operates across life science, healthcare and electronics. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere.View full profile

More Merck

Established as a pioneer in AI-driven drug discovery, Standigm utilizes cutting-edge artificial intelligence to streamline the development of pharmaceuticals. With a robust AI platform that includes biology and chemistry components, Standigm accelerates the discovery of novel drug targets and molecular designs, aiming to revolutionize patient care globally.View full profile

Topics